Development of this evidence summary

This evidence summary was developed for NICE by Bazian Ltd. The Interim process statement sets out the process NICE uses to select topics for the evidence summaries for unlicensed/off-label medicines and how the summaries are developed, quality assured and approved for publication.

Project team

Bazian Ltd

Peer reviewers and contributors

Emma Chambers, Patient and Public Involvement Programme, NICE

Jason Miller, Pfizer

Richard Woodfield, MHRA

Expert advisers

Professor Ian Roberts, Director, Clinical Trials Unit, London School of Hygiene & Tropical Medicine

Declarations of interest

No relevant interests declared.